STA
CC icon

Summit Trail Advisors’s Chemours CC Stock Holding History

Summit Trail Advisors’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.46M Sell
66,156
-26,382
-29% -$459K 0.02% 741
2025
Q4 		$1.09M Buy
92,538
+38,956
+73% +$500K 0.02% 770
2025
Q3 		$849K Buy
53,582
+28,324
+112% +$411K 0.01% 915
2025
Q2 		$289K Buy
+25,258
New +$285K 0.01% 936
2018
Q1 		– Sell
-1,179
Closed -$60K – 630
2017
Q4 		$60K Buy
+1,179
New +$61.8K 0.01% 771

Other funds holding CC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
WHCM
Wolf Hill Capital Management Greenwich, Connecticut $1.03B AUM 80.44% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Summit Trail Advisors's CC Position: Q1 2026 in Review

Summit Trail Advisors reduced its Chemours (CC) stake by 29% in Q1 2026, selling an estimated $459K and leaving 66,156 shares worth $1.46M. The position accounts for 0.02% of the portfolio, ranked #741.

Summit Trail Advisors first reported a position in CC in Q4 2017 and has held it in 5 quarters since. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.

  • Summit Trail Advisors held 66,156 shares of Chemours worth $1.46M as of Q1 2026.
  • Summit Trail Advisors sold 26,382 Chemours shares in Q1 2026, an estimated $459K.
  • Chemours made up 0.02% of Summit Trail Advisors's portfolio in Q1 2026, its #741 holding.
  • Summit Trail Advisors first reported a position in Chemours in Q4 2017 and has held it in 5 quarters since.
  • 448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on Summit Trail Advisors's 13F filing for Q1 2026, filed 12 May 2026.